# Patient Square Capital LP 13F holdings Q2 2026: $646 million

Patient Square Capital LP reported $646 million in 13F securities across 23 positions for the quarter ended June 30, 2026, in a holdings report filed August 12, 2026. Its largest holding was Roivant Sciences LTD at $284 million, 44.0% of the reported value. Since Q1 2026 it opened 6 new positions and exited 12.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $645,523,811
- Positions: 23
- Filed: August 12, 2026
- Report type: 13F holdings report
- CIK: 1819257
- Form 13F file number: 028-22927
- Business address: 2884 Sand Hill Road, Suite 100, Menlo Park, CA 94025
- SEC filing: [0001819257-26-000005](https://www.sec.gov/Archives/edgar/data/1819257/000181925726000005/0001819257-26-000005-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/patient-square-capital-lp-312203)

## Top 23 holdings by value

The largest of 23 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Roivant Sciences LTD](https://specstream.ai/data/institutional-holders/roivant-sciences-ltd-g76279101) | SHS | 8,020,928 | $283.9 million | -145,119 |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 276,000 | $51.7 million | New |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 260,500 | $30.5 million | +30,500 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 206,500 | $27.5 million | +85,255 |
| [Beone Medicines LTD](https://specstream.ai/data/institutional-holders/beone-medicines-ltd-07725l102) | SPONSORED ADS | 90,020 | $25.7 million | +9,478 |
| [Pharvaris N V](https://specstream.ai/data/institutional-holders/pharvaris-n-v-n69605108) | COM | 671,209 | $23.2 million | +178,209 |
| [Argenx Se](https://specstream.ai/data/institutional-holders/argenx-se-04016x101) | SPONSORED ADR | 23,000 | $21.3 million | -13,718 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 37,120 | $20.1 million | New |
| [Belite Bio Inc](https://specstream.ai/data/institutional-holders/belite-bio-inc-07782b104) | SPONSORED ADS | 110,000 | $16.9 million | -6,684 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 425,000 | $16.4 million | -171,000 |
| [DBV Technologies S a](https://specstream.ai/data/institutional-holders/dbv-technologies-s-a-23306j309) | SPONSORED ADS | 909,474 | $14.9 million | +215,940 |
| [Xenon Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/xenon-pharmaceuticals-inc-98420n105) | COM | 220,000 | $13.3 million | -7,000 |
| [Biontech Se](https://specstream.ai/data/institutional-holders/biontech-se-09075v102) | SPONSORED ADS | 134,429 | $12.5 million | New |
| [Arcus Biosciences Inc](https://specstream.ai/data/institutional-holders/arcus-biosciences-inc-03969f109) | COM | 355,800 | $11 million | +160,800 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 212,500 | $10.8 million | +12,500 |
| [Dianthus Therapeutics Inc](https://specstream.ai/data/institutional-holders/dianthus-therapeutics-inc-252828108) | COM | 108,000 | $10.5 million | +14,118 |
| [Allogene Therapeutics Inc](https://specstream.ai/data/institutional-holders/allogene-therapeutics-inc-019770106) | COM | 5,050,000 | $10.5 million | +1,600,000 |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 720,000 | $10.3 million | -75,000 |
| [Arcutis Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/arcutis-biotherapeutics-inc-03969k108) | COM | 370,000 | $9.7 million | -30,645 |
| [C4 Therapeutics Inc](https://specstream.ai/data/institutional-holders/c4-therapeutics-inc-12529r107) | COM STK | 1,608,815 | $7.5 million | New |
| [Inventiva SA](https://specstream.ai/data/institutional-holders/inventiva-sa-46124u107) | ADS | 1,967,171 | $7.4 million | New |
| [Kymera Therapeutics Inc](https://specstream.ai/data/institutional-holders/kymera-therapeutics-inc-501575104) | COM | 47,500 | $5.4 million | -52,500 |
| [Faeth Therapeutics Inc](https://specstream.ai/data/institutional-holders/faeth-therapeutics-inc-81728a207) | COM NEW | 175,050 | $4.4 million | New |

## New positions in Q2 2026

6 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 276,000 | $51.7 million |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 37,120 | $20.1 million |
| [Biontech Se](https://specstream.ai/data/institutional-holders/biontech-se-09075v102) | SPONSORED ADS | 134,429 | $12.5 million |
| [C4 Therapeutics Inc](https://specstream.ai/data/institutional-holders/c4-therapeutics-inc-12529r107) | COM STK | 1,608,815 | $7.5 million |
| [Inventiva SA](https://specstream.ai/data/institutional-holders/inventiva-sa-46124u107) | ADS | 1,967,171 | $7.4 million |
| [Faeth Therapeutics Inc](https://specstream.ai/data/institutional-holders/faeth-therapeutics-inc-81728a207) | COM NEW | 175,050 | $4.4 million |

## Positions exited in Q2 2026

12 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 157,500 | $25.8 million |
| [Legend Biotech Corp](https://specstream.ai/data/institutional-holders/legend-biotech-corp-52490g102) | SPONSORED ADS | 990,000 | $17.9 million |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 210,000 | $15.1 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 95,000 | $10.8 million |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 80,000 | $9.6 million |
| [Perspective Therapeutics Inc](https://specstream.ai/data/institutional-holders/perspective-therapeutics-inc-46489v302) | COM NEW | 1,625,000 | $6.8 million |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 331,000 | $6.3 million |
| [Harrow Inc](https://specstream.ai/data/institutional-holders/harrow-inc-415858109) | COM | 165,209 | $5.8 million |
| [Protara Therapeutics Inc](https://specstream.ai/data/institutional-holders/protara-therapeutics-inc-74365u107) | COM STK | 1,030,846 | $5.4 million |
| [Cytomx Therapeutics Inc.](https://specstream.ai/data/institutional-holders/cytomx-therapeutics-inc-23284f105) | COM | 1,085,790 | $5.1 million |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 136,315 | $3.8 million |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 1,000 | $50,440 |

## Also on SpecStream

- [Patient Square Capital LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1819257/000181925726000005/0001819257-26-000005-index.htm)
- [Patient Square Capital LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/patient-square-capital-lp-312203)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Menlo Park, California

- [Software development companies in Menlo Park, California](https://specstream.ai/data/businesses/software-development-companies/menlo-park-california-united-states)
- [Real estate firms in Menlo Park, California](https://specstream.ai/data/businesses/real-estate-firms/menlo-park-california-united-states)
- [Law firms in Menlo Park, California](https://specstream.ai/data/businesses/law-firms/menlo-park-california-united-states)
- [Investment management firms in Menlo Park, California](https://specstream.ai/data/businesses/investment-management-firms/menlo-park-california-united-states)
- [Business consulting firms in Menlo Park, California](https://specstream.ai/data/businesses/business-consulting-firms/menlo-park-california-united-states)
- [Scientific laboratories in Menlo Park, California](https://specstream.ai/data/businesses/scientific-laboratories/menlo-park-california-united-states)
